Lazard Asset Management LLC Acquires 138,636 Shares of Sotera Health Company $SHC

Lazard Asset Management LLC boosted its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 313.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,931 shares of the company’s stock after buying an additional 138,636 shares during the quarter. Lazard Asset Management LLC’s holdings in Sotera Health were worth $2,623,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Sculptor Capital LP boosted its position in Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after acquiring an additional 7,658,200 shares in the last quarter. Sachem Head Capital Management LP raised its position in shares of Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after acquiring an additional 3,735,000 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after acquiring an additional 2,756,583 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Sotera Health by 1,206.2% during the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after purchasing an additional 2,644,831 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Sotera Health during the 4th quarter worth $45,278,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is available at this link. 15.36% of the stock is owned by company insiders.

Sotera Health Stock Up 0.1%

Shares of SHC stock opened at $17.86 on Friday. The stock’s fifty day moving average price is $16.87 and its 200 day moving average price is $16.36. Sotera Health Company has a 1-year low of $11.00 and a 1-year high of $19.85. The company has a market cap of $5.09 billion, a price-to-earnings ratio of 43.56 and a beta of 1.76. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the previous year, the firm earned $0.14 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, research analysts expect that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

SHC has been the topic of several analyst reports. UBS Group set a $19.00 target price on Sotera Health in a research note on Wednesday, June 24th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target for the company. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.25.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.